177 related articles for article (PubMed ID: 21800052)
41. Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines.
Siervo-Sassi RR; Marrangoni AM; Feng X; Naoumova N; Winans M; Edwards RP; Lokshin A
Cancer Lett; 2003 Feb; 190(1):61-72. PubMed ID: 12536078
[TBL] [Abstract][Full Text] [Related]
42. Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703.
Miao L; Yi P; Wang Y; Wu M
Eur J Biochem; 2003 Jul; 270(13):2721-31. PubMed ID: 12823542
[TBL] [Abstract][Full Text] [Related]
43. Akt inhibitor enhances apoptotic effect of carboplatin on human epithelial ovarian carcinoma cell lines.
Lee CS; Kim YJ; Jang ER; Myung SC; Kim W
Eur J Pharmacol; 2010 Apr; 632(1-3):7-13. PubMed ID: 20096282
[TBL] [Abstract][Full Text] [Related]
44. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
Gillespie S; Borrow J; Zhang XD; Hersey P
Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334
[TBL] [Abstract][Full Text] [Related]
45. HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells.
Lee DH; Sung KS; Bartlett DL; Kwon YT; Lee YJ
Cell Signal; 2015 Feb; 27(2):293-305. PubMed ID: 25446253
[TBL] [Abstract][Full Text] [Related]
46. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
[TBL] [Abstract][Full Text] [Related]
47. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage.
Jin CY; Park C; Moon SK; Kim GY; Kwon TK; Lee SJ; Kim WJ; Choi YH
Anticancer Drugs; 2009 Sep; 20(8):713-22. PubMed ID: 19617819
[TBL] [Abstract][Full Text] [Related]
48. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
[TBL] [Abstract][Full Text] [Related]
49. Involvement of Bid in the crosstalk between ferroptotic agent-induced ER stress and TRAIL-induced apoptosis.
Kim JH; Najy AJ; Li J; Luo X; Kim HC; Choudry MHA; Lee YJ
J Cell Physiol; 2022 Nov; 237(11):4180-4196. PubMed ID: 35994698
[TBL] [Abstract][Full Text] [Related]
50. Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells.
Griffin D; Wittmann S; Guo F; Nimmanapalli R; Bali P; Wang HG; Bhalla K
Gynecol Oncol; 2003 Apr; 89(1):37-47. PubMed ID: 12694652
[TBL] [Abstract][Full Text] [Related]
51. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells.
Lacour S; Micheau O; Hammann A; Drouineaud V; Tschopp J; Solary E; Dimanche-Boitrel MT
Oncogene; 2003 Mar; 22(12):1807-16. PubMed ID: 12660816
[TBL] [Abstract][Full Text] [Related]
53. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells.
Weng C; Li Y; Xu D; Shi Y; Tang H
J Biol Chem; 2005 Mar; 280(11):10491-500. PubMed ID: 15637055
[TBL] [Abstract][Full Text] [Related]
54. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
55. Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis.
Kim JY; Kim YH; Chang I; Kim S; Pak YK; Oh BH; Yagita H; Jung YK; Oh YJ; Lee MS
Oncogene; 2002 May; 21(20):3139-48. PubMed ID: 12082629
[TBL] [Abstract][Full Text] [Related]
56. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
Izeradjene K; Douglas L; Delaney AB; Houghton JA
Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
[TBL] [Abstract][Full Text] [Related]
57. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
58. Heat shock protects HCT116 and H460 cells from TRAIL-induced apoptosis.
Ozören N; El-Deiry W
Exp Cell Res; 2002 Dec; 281(2):175-81. PubMed ID: 12460647
[TBL] [Abstract][Full Text] [Related]
59. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.
Deng Y; Lin Y; Wu X
Genes Dev; 2002 Jan; 16(1):33-45. PubMed ID: 11782443
[TBL] [Abstract][Full Text] [Related]
60. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB
Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
